Published: 1 May 2026
Author(s): Mario Mallardo, Pasquale Perrone Filardi, Claudio Micheletto, Nicola Montano, Andrea Spampinato, Maurizio Volterrani, Giovanni Battista Zito, Sergio Agosti, Enrico Avogadri, Christian Basile, Michele Gabriele, Alberto M. Marra, Anna Vittoria Mattioli, Alex Micanti, Savina Nodari, Ugo Oliviero, Stefania Paolillo, Gennaro Ratti, Antonio Ruvolo, Andrea Salzano, Regina Sorrentino, Antonio Cittadini
Issue: May 2026
Section: Original Article

Heart failure (HF), defined as the inability of the heart to meet the metabolic requirements of peripheral tissues, or to do so only at the expense of elevated ventricular filling pressures, represents one of the most clinically and socioeconomically burdensome chronic conditions [1]. It affects approximately 1–3 % of the Western population, with prevalence and incidence increasing exponentially with advancing age [1]. Despite major therapeutic advances, prognosis remains poor, with >30 % of patients dying within one year after their first hospitalization for HF [1].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness